Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nadia Valin

Showing results (21-30 of 58) with videos related to

Pageof 6
Sort By:
American Journal of Health Behavior|November 5, 2022
Risk Prediction Score for Screening Asymptomatic Sexually Transmitted Infections in HIV-positive French Men Who Have Sex with Men (ANRS 9520 DRIVER)Martin Duracinsky, Svetlane Dimi, Maria Patrizia Carrieri, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 25, 2024
Sexual behaviors and risk of extended-spectrum β-lactamase-producing Enterobacterales carriage: A cross-sectional analysisAnders Boyd, Pauline Mathieu, Ugo Françoise, et al.
Plos One|June 24, 2021
Trends in asymptomatic STI among HIV-positive MSM and lessons for systematic screeningEric Farfour, Svetlane Dimi, Olivier Chassany, et al.
Critical Care (London, England)|February 17, 2010
Risk factors for multidrug resistant bacteria and optimization of empirical antibiotic therapy in postoperative peritonitisPascal Augustin, Nathalie Kermarrec, Claudette Muller-Serieys, et al.
BMC Infectious Diseases|September 4, 2023
Prophylaxis by doravirine-lamivudine-tenofovir disoproxil fumarate or elvitegravir-cobicistat-emtricitabine-tenofovir alafenamide after sexual exposure to HIVInès Devred, Kick Kayembe, Nadia Valin, et al.
Plos Neglected Tropical Diseases|December 28, 2007
Risk factors for buruli ulcer: a case control study in CameroonRégis Pouillot, Gonçalo Matias, Christelle Mbondji Wondje, et al.
International Journal of Public Health|January 2, 2023
Prevalence of Antimicrobial Resistance and Infectious Diseases in a Hospitalised Migrant Population in Paris, France, a Retrospective StudySarah Stabler, Olivier Paccoud, Léa Duchesne, et al.
The Journal of Antimicrobial Chemotherapy|August 9, 2011
Efficacy and safety of a switch to unboosted atazanavir in combination with nucleoside analogues in HIV-1-infected patients with virological suppression under antiretroviral therapyJuliette Pavie, Raphael Porcher, Carlo Torti, et al.
Sexually Transmitted Infections|November 6, 2021
Young people seeking sexual health care but not returning for resultsTetiana Kyrychenko, Nadia Valin, Thibault Chiarabini, et al.
AIDS (London, England)|July 11, 2017
Metabolic syndrome and obesity are the cornerstones of liver fibrosis in HIV-monoinfected patientsMaud Lemoine, Karine Lacombe, Jean P Bastard, et al.
Pageof 6

Showing results (21-30 of 58) with videos related to

Sort By:
Pageof 6
American Journal of Health Behavior|November 5, 2022
Risk Prediction Score for Screening Asymptomatic Sexually Transmitted Infections in HIV-positive French Men Who Have Sex with Men (ANRS 9520 DRIVER)Martin Duracinsky, Svetlane Dimi, Maria Patrizia Carrieri, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 25, 2024
Sexual behaviors and risk of extended-spectrum β-lactamase-producing Enterobacterales carriage: A cross-sectional analysisAnders Boyd, Pauline Mathieu, Ugo Françoise, et al.
Plos One|June 24, 2021
Trends in asymptomatic STI among HIV-positive MSM and lessons for systematic screeningEric Farfour, Svetlane Dimi, Olivier Chassany, et al.
Critical Care (London, England)|February 17, 2010
Risk factors for multidrug resistant bacteria and optimization of empirical antibiotic therapy in postoperative peritonitisPascal Augustin, Nathalie Kermarrec, Claudette Muller-Serieys, et al.
BMC Infectious Diseases|September 4, 2023
Prophylaxis by doravirine-lamivudine-tenofovir disoproxil fumarate or elvitegravir-cobicistat-emtricitabine-tenofovir alafenamide after sexual exposure to HIVInès Devred, Kick Kayembe, Nadia Valin, et al.
Plos Neglected Tropical Diseases|December 28, 2007
Risk factors for buruli ulcer: a case control study in CameroonRégis Pouillot, Gonçalo Matias, Christelle Mbondji Wondje, et al.
International Journal of Public Health|January 2, 2023
Prevalence of Antimicrobial Resistance and Infectious Diseases in a Hospitalised Migrant Population in Paris, France, a Retrospective StudySarah Stabler, Olivier Paccoud, Léa Duchesne, et al.
The Journal of Antimicrobial Chemotherapy|August 9, 2011
Efficacy and safety of a switch to unboosted atazanavir in combination with nucleoside analogues in HIV-1-infected patients with virological suppression under antiretroviral therapyJuliette Pavie, Raphael Porcher, Carlo Torti, et al.
Sexually Transmitted Infections|November 6, 2021
Young people seeking sexual health care but not returning for resultsTetiana Kyrychenko, Nadia Valin, Thibault Chiarabini, et al.
AIDS (London, England)|July 11, 2017
Metabolic syndrome and obesity are the cornerstones of liver fibrosis in HIV-monoinfected patientsMaud Lemoine, Karine Lacombe, Jean P Bastard, et al.
Pageof 6